Peptide Email Marketing That Actually Prints

if your peptide store is doing real ad spend and email is under 20% of revenue, you are leaking money every single day. a properly built peptide email program drives 25-35% of total revenue. we've seen brands cross 40% in months where paid was constrained. the split inside that number matters more than the number itself: about 60-70% should come from automated flows that run whether or not anyone touched the account this week, and 30-40% from campaigns.

the reason email matters more for peptides than for a normal ecom category is simple. you cannot say most of what you want to say in a meta ad. ad accounts get restricted for the exact language that sells. email is the channel where you get to educate at length, build the trust that a $180 order requires, and own the customer relationship outside of a platform that can turn you off on a tuesday.

the revenue math nobody runs

before you write a single email, do this arithmetic. take your monthly revenue, multiply by 0.30. that's your email target. now take your current email revenue from your ESP's attribution and subtract. the gap is what you are leaving on the table annually times twelve. for a brand doing $400k/mo with email at 12%, the gap is roughly $72k a month. that's an entire hire, or three months of a good creative program, sitting in flows you haven't built.

the second number: revenue per recipient (RPR). campaigns to a healthy list should land $0.15-$0.60 per recipient for a peptide brand with $120-250 AOV. flows will be far higher — a checkout abandon flow routinely does $3-8 per recipient because the intent is enormous. if your campaign RPR is under $0.10 you have a list quality problem, not a copy problem.

the eight flows, in build order

do not build these in parallel. build in the order below, because each one compounds and the early ones catch the most traffic.

1. 1.checkout abandon (highest intent, fastest payback) — 3 emails over 48 hours, trigger at 45-60 minutes
2. 2.welcome / new subscriber — 5-6 emails over 12 days, the single biggest lever on first purchase rate
3. 3.cart abandon — 3 emails, trigger at 4 hours to avoid overlapping the checkout flow
4. 4.post-purchase education — 4-5 emails timed to the actual usage cycle, not to calendar convenience
5. 5.reorder / replenishment — trigger at 70-75% of a typical supply cycle, 3 emails
6. 6.browse abandon — 2 emails, only for viewers who hit a product page twice or spent 60+ seconds
7. 7.winback — 4 emails starting at 60 days past expected reorder
8. 8.sunset / suppression — 2 emails, then suppress, to protect deliverability

everything past those eight is optimization. brands skip to fancy stuff (quiz branching, predictive AI send times) while their checkout abandon flow is a single email with a 10% discount. fix the base.

segmentation that actually changes behavior

the segment list most brands use is engagement-based only: 30-day openers, 60-day, 90-day. that's a deliverability tool, not a marketing tool. for peptides you want behavioral and lifecycle segments layered on top.

• —never-purchased engaged (opened in 60 days, zero orders) — the biggest untapped pool in almost every account, usually 40-60% of the list
• —one-time buyers past 45 days — the single most valuable segment in the business; converting these to a second order is where LTV is made
• —2+ order customers — different message entirely; these people want new products and depth, not discounts
• —high AOV buyers ($250+) — bundle and multi-month offers land here, never send these people a 10%-off
• —lapsed 120-180 days — winback territory, run separately from the flow
• —recent purchasers (last 21 days) — SUPPRESS from promo campaigns; nothing tanks trust like a discount email three days after someone paid full price

that last one is not optional. discount-after-purchase is the number one driver of support tickets and refund requests in this category, and it trains your best customers to wait.

subject line principles, not swipe files

swipe files rot. principles don't. four rules we hold every subject line to:

1. 1.honest — the subject must describe what is actually in the email. CAN-SPAM requires it and, more practically, deceptive subjects destroy the open rates of the next twenty sends. no fake 'RE:' or 'FWD:' prefixes, no fake shipping notifications, no fake reply threads.
2. 2.specific over clever — 'your 3rd month is where it changes' beats 'don't miss out'. specificity implies you know something.
3. 3.short on mobile — 30-45 characters clears the iPhone preview cutoff. everything past that is decoration.
4. 4.the preview text is a second subject line — most brands waste it on 'view in browser'. use it to complete the thought the subject started.

benchmarks to hold yourself to in this category, on a properly warmed and hygienic list: 35-50% open rate (post-MPP inflation, so treat it as directional), 1.5-3% click rate on campaigns, 5-15% click rate on high-intent flow emails, under 0.1% spam complaint rate, under 0.5% bounce rate. if complaints go above 0.1% you have a consent problem and you are weeks away from a deliverability collapse.

writing peptide email copy that stays compliant

this is where most brands blow themselves up. the rule is boring and absolute: you cannot make disease, treatment, cure, prevention, or diagnosis claims about a product that isn't an approved drug for that use. 'treats obesity', 'cures inflammation', 'reverses aging', 'replaces your prescription' — all of these are a problem, and they are a problem in email exactly like they are on the product page, because the FTC and FDA read email.

what you can do is far more interesting than what you can't:

• —education about mechanism in neutral, research-framed language, with 'research use only / not medical advice' where the product warrants it
• —customer experience stories in the customer's own words, with the standard disclosure that individual results vary
• —practical content — storage, reconstitution basics, shipping, cold chain, what to expect from your order
• —product comparison and sourcing transparency, which for peptides is a genuine differentiator: COAs, third-party testing, batch numbers
• —brand and founder narrative, which converts better in this category than almost any offer

the brands that win at peptide email aren't the ones with the boldest claims. they're the ones the customer believes. transparency is the offer.

campaign cadence

two to three campaigns a week is the sweet spot for a list under 100k. one is education or story, one is offer or product, and the optional third is a re-send to non-openers with a different subject line 48-72 hours later. that re-send alone usually adds 20-30% to a campaign's revenue and costs you nothing but a segment.

sending less than once a week is worse than sending three times a week. an inactive list decays — the inbox providers read low engagement over time as low relevance, and your placement drops. consistency is a deliverability strategy, not just a revenue strategy.

what to measure weekly

• —flow revenue vs campaign revenue split (target 60/40 to 70/30)
• —email as % of total revenue (target 25-35%)
• —revenue per recipient by campaign type
• —list growth rate net of unsubscribes and suppressions
• —spam complaint rate by campaign — one bad send is a visible spike
• —first-to-second purchase conversion rate, which the whole program ultimately exists to move

if you only track open rate you will optimize subject lines forever and never move revenue. RPR and the flow/campaign split are the two numbers that actually predict the size of the channel.